Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis

Rheumatology International

Volumn 23, Issue 5, 2003, Pages 258-261

  Mangge, Harald ^a   Heinzl, Bernd ^b   Grubbauer, Hans Michael ^b   El Shabrawi, Yosuf ^b   Schauenstein, Konrad ^c  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b University Eye Clinic   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Infliximab; Juvenile idiopathic arthritis; Treatment; Uveitis

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; DRUG WITHDRAWAL; ERYTHEMA; HUMAN; HYPERTENSION; IDIOPATHIC DISEASE; IRIDOCYCLITIS; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; MALE; MEDICAL SPECIALIST; MORNING STIFFNESS; PAIN; PEDIATRICS; POLYARTHRITIS; PRIORITY JOURNAL; SCORING SYSTEM; SEROLOGY; SIDE EFFECT; SINGLE DRUG DOSE; TACHYCARDIA; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; C-REACTIVE PROTEIN; HUMANS; MALE; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; UVEITIS, ANTERIOR;

EID: 0141923172     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-003-0308-1     Document Type: Article

References (19)

1. Feldmann M, Maini RN (1999) The role of cytokines in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 38 [Suppl 2]:3-7
2. Mangge H, Schauenstein K (1998) Cytokines in juvenile rheumatoid arthritis. Cytokine 10:471-480
3. Mangge H, Kenzian H, Gallistl S, Neuwirth G, Kaulfersch W, Beaufort F, Muntean W, Schauenstein K (1995) Serum cytokines in juvenile rheumatoid arthritis (JRA). Correlation with conventional inflammatory parameters and clinical subtypes. Arthritis Rheum 38:211-219
4. Lipsky PE, Van-der-Heijde DM, St-Clair EW, Furst DE, Breedveld FC, Kalden JR (2000) Infliximab and MTX in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial with concomitant therapy study group. N Engl J Med 343:1594-1602
5. Geborek P, Crnkic M, Petersson F, Saxne T (2002) Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden. Ann Rheum Dis 61:793-798
6. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN (2001) Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet 358:295-296
7. Serrano MS, Schmidt-Sommerfeld E, Kilbaugh TJ, Brown RF, Udall JN Jr, Mannick EE (2001) Use of infliximab in pediatric patients with inflammatory bowel disease. Ann Pharmacother 35:823-828
8. Hyams JS, Markowitz J, Wyllie R (2000) Use of Infliximab in the treatment of Crohn's disease in children and adolescents. J Pediatr 137:192-196
9. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, OrozcoAlcala J, Prieur AM (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997. J Rheumatol 25:1991-1994
10. Thorne JE, Brucker AJ (2000) Choroidal white lesions as an early manifestation of sarcoidosis. Retina 20:8-15
11. Kietz DA, Pepmueller PH, Moore TL (2002) Therapeutic use of etanercept in polyarticular course juvenile idiopathic arthritis over a two year period. Ann Rheum Dis 61:171-173
12. Gerloni V, Pontikaki I, Desiati F, Lupi E, Gattinara M, Fantini F (2001) Evaluation of disease activity, disability and quality of life in patients with persistently active refractory juvenile chronic arthritis after one year treatment with monoclonal anti-tumor necrosis factor-α antibody (infliximab). Abstract 165, Arthritis Rheum 44:80
13. Honkanen V, Lappi M, Koskinen L, Lindahl P, Lahdenne P (2001) Infliximab treatment in the refractory chronic uveitis of juvenile idiopathic arthritis (JIA). Abstract 1438, Arthritis Rheum 44:292
14. Smith JR, Levinson RD, Holland GN, Jabs DA, Robinson MR, Whitcup SM, Rosenbaum JT (2001) Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 45:252-257
15. El-Shabrawi Y, Hermann S (2002) Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology 10:2342-2346
16. Prevoo M, van Riel P, Van't Hof, van Rijswijk M, van Leeuwen M, Kuper H, van de Putte L (1993) Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis. Br J Rheumatol 32:589-594
17. Goossens PH, Verburg RJ, Breedveld FC (2001) Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy. Ann Rheum Dis 60:637
18. Reiff A, Takei S, Sadeghi S, Stout A, Shaham B, Bernstein B, Gallagher K, Stout T (2002) Etanercept in children with treatment-resistant uveitis. Arthritis Rheum 44:1411-1415
19. Bloch-Michel E, Nussenblatt RB (1987) International uveitis study group recommendations for the evaluation of intraocular inflammatory diseases. Am J Ophthalmol 103:234-235